SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Norris Medicines informs about non-applicability of annual secretarial compliance report

28 Jun 2021 Evaluate

Norris Medicines has informed that paid up Equity Share Capital of the Company is less than Rs 10 crores and Net worth of the Company is less than Rs 25 crores. Hence, Annual Secretarial compliance Report under Regulation 24A of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with Regulation 15(2) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 shall not apply to the Company. The company has enclosed the certificate relating to non-applicability of Regulation 24A of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 issued from Devesh R. Desai, Practicing Company Secretary.

The above information is a part of company’s filings submitted to BSE.


Norris Medicines Share Price

14.97 0.22 (1.49%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×